Tech startups are popping up across industries from real estate to oil and gas, and these three founders are among the leaders in technology. Courtesy images

Often, technology and innovation are mistaken for each other. While not mutually exclusive, both tech and innovation work well together in Houston across all industries — from oil and gas to real estate and social media. These three founders engaged technology for their individual startups.

Srini Katta, founder and CEO of Social Chains

Courtesy of Social Chains

As a social media user, your data is already out there and being used for marketing purposes. But, rather than the Facebooks or Googles of the world making a profit, Srini Katta wanted to create a platform where users made a profit off their own data.

"On our platform, the user is a stakeholder. Our platform distributes 50 percent of the profits to the users," he says.

Social Chains already has 5,000 users and, Katta says, that's with little to no marketing efforts, which Katta is about to launch.

Martin Kay, founder and CEO of Entera Technology

Courtesy of Entera

Martin Kay, who splits his time between Houston and the Bay Area for his startup Entera Technologies, knew there had to be a better way for people searching for a home to buy. He drew a comparison between homebuyers and Netflix viewers to create Entera's software.

"We're a little bit like Netflix," he says. "They go out and get content from everyone, and they begin to watch your behavior. So, Netflix has 2,000 profiles and you probably fit five or six of those. We have almost 100 profiles and what we do is say, we're going to understand what you want, watch your behavior and instead of giving you 40,000 properties on a big map, we actually match you based on your preferences, to the five or six houses that are best for you."

Houston-based Entera has grown as the platform loads more and more data for its users to engage with.

Luther Birdzell, CEO and founder of OAG Analytics

Courtesy of OAG Analytics

Luther Birdzell always knew he wanted to run his own company, but the software and analytics professional worked in various industries before realizing that oil and gas had a huge opportunity for savings using analytics. He founded OAG Analytics in 2013 to help provide a solution for these companies.

"When I founded OAG Analytics, our mission then — and still is today — was to build a platform for the upstream oil and gas industry that enables them to manage their data, introduces world-class machine learning in minutes without having to write a single line of code, and allow them to run simulations on the resulting analysis," Birdzell says.

The company has grown to 25 employees and tripled its revenue last year. The team is forecasting another year of high grow for 2019.


This Houston company has the key to a more exact searching process when it comes to finding a new home to buy. Courtesy photo

Tech company uses machine learning to buy homes in Houston

game changer

For most consumers, the home buying process includes a very specific online search. People specify their neighborhood requirements, the number of bedrooms or bathrooms, backyard size, and more — yet still, the search results in a staggering amount of homes. It's way more than anyone can reasonably look at.

That's where Martin Kay and Entera Technology, the company he founded and is CEO of, come in. Kay, a 20-year veteran of the tech sector, who's bought multiple homes as rental properties, realized the way to solve the problem of that kind of search engine overload was through machine learning. He now works with some of the largest home-buying companies in the world, helping them find properties that match the specifications they have to attract the clients they want.

"All residential real estate is a consumer product," he says. "Ultimately, the people who are going to live in that home care most about, is it a nice home with a big backyard neat good schools, is it safe? The [home buying] companies are trying to figure out what do the end consumers really care about so we can give them exactly what they need?"

To do so, Entera collects data — lots and lots of it. Kay and his team have taught their software programs what a chef's kitchen is, for example. They did so by compiling tens of thousands of photos of kitchens and telling the software, "This is a kitchen." Then, they taught it to recognize what makes a chef's kitchen — a larger size, more than one sink, high-end appliances. They used the same techniques in identifying things like millennial-friendly neighborhoods or neighborhoods that were up-and-coming on the real estate scene. They draw from listings available with the Houston Association of Realtors and beyond, a vast array of tens of thousands of homes.

Officially launched in 2017, Entera blends its data collection and analysis with on-the-ground service. After Entera's proprietary software collects what it thinks home-buying companies want, members of Entera's service team go out to look at the homes.

"We're a little bit like Netflix," he says. "They go out and get content from everyone, and they begin to watch your behavior. So, Netflix has 2,000 profiles and you probably fit five or six of those. We have almost 100 profiles and what we do is say, we're going to understand what you want, watch your behavior and instead of giving you 40,000 properties on a big map, we actually match you based on your preferences, to the five or six houses that are best for you."

While Entera has been working with larger home-buying companies — like firms that buy tens of thousands of homes every year — Kay says they have begun working with smaller entities, and he figures within the next few years, Entera will be using the same data collection and machine learning to work with individual home buyers.

Based in Houston, Entera has operations in New York and San Francisco as well. The company has 17 full-time employees, along with approximately 100 contractors in its markets. And while Kay understand a human touch is needed in business, he loves that he can use a data model to present unbiased opinions to his clients.

"[Real estate] actually affects people's lives meaningfully," Kay says. "Real estate data — where you live, what your neighborhood is, how you make that choice — …this data matters to people in a way they can tangibly touch and understand and feel. We can help people make what are big, complex choices that are often highly ambiguous. I love it because it matters. You can measure how it matters immediately."

Data-driven tech

Courtesy of Entera

Entera focuses on collecting data and analysis and pairs it with on-the-ground service. After Entera's proprietary software collects what it thinks home-buying companies want, members of Entera's service team go out to look at the homes.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”